Diabetes complications

Biological aging and the incidence and progression of diabetic retinopathy and kidney disease in type 2 diabetes mellitus: A prospective cohort study

Diabetes Res Clin PractPublished Prospective cohort study

Authors' conclusion

PhenoAge acceleration, a routine biomarker-based measure of biological aging, was associated with microvascular complications in T2DM.

Study context

Population
Adults with T2D; Phenotypic age (PhenoAge) calculated from nine routine biomarkers at baseline and follow-up
Participants
8,194 adults
Exposure
Highest vs lowest tertile of baseline PhenoAge acceleration
Outcome
Incidence and progression of DR (deep-learning graded) and DKD (Kidney Disease: Improving Global Outcomes criteria)
Methodological detailsmodified Poisson models adjusted for conventional risk factors
  • Modified Poisson models adjusted for conventional risk factors

Main finding

As reported in the abstract

Incident DR, DKD and concurrent DR-DKD
Each group vs lowest tertileEstimate (95% CI)
Highest tertile
RR (incident DR) 1.56(1.10–2.23)
Highest tertile
RR (incident DKD) 1.30(1.10–1.54)
Highest tertile
RR (concurrent DR and DKD) 3.24(1.56–6.76)

Observational data: associations, not effects.

Further findings

OutcomeRR (CI)
DKD progression (participants with baseline DKD)2.04 (1.60–2.59)

Diabetic retinopathy (DR) progression (participants with baseline DR)

Highest tertile of PhenoAge acceleration not associated with increased risk of DR progression

Longitudinal increase in PhenoAge acceleration and incident diabetic kidney disease (DKD)

RR for incident DKD with longitudinal increase
1.36 (CI 1.14-1.62)

Decrease in PhenoAge acceleration and DKD progression

RR for DKD progression with decrease, lower risk
0.59 (CI 0.41-0.85)

Original publication

Biological aging and the incidence and progression of diabetic retinopathy and kidney disease in type 2 diabetes mellitus: A prospective cohort study. Diabetes Res Clin Pract. Published 8 July 2026. doi:10.1016/j.diabres.2026.113424

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.